BCHE and dementia: In this comparative effectiveness study of 3612 Medicare beneficiaries with dementia receiving cholinesterase inhibitors who initiated memantine, those who discontinued the cholinesterase inhibitor had similar 1-year mean long-term care institutionalization-free days and all-cause mortality, but had a lower risk of fall-related injury compared with those who continued the cholinesterase inhibitor.